Sanofi faces make-or-break verdict on big dengue vaccine bet

* Sales could top 1 bln euros but project is risky -analysts
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.